Skip to main content

Atrial fibrillation and clinical outcomes 1 to 3 years after myocardial infarction.

Publication ,  Journal Article
Carnicelli, AP; Owen, R; Pocock, SJ; Brieger, DB; Yasuda, S; Nicolau, JC; Goodman, SG; Cohen, MG; Simon, T; Westermann, D; Hedman, K ...
Published in: Open heart
December 2021

Atrial fibrillation (AF) and myocardial infarction (MI) are commonly comorbid and associated with adverse outcomes. Little is known about the impact of AF on quality of life and outcomes post-MI. We compared characteristics, quality of life and clinical outcomes in stable patients post-MI with/without AF.The prospective, international, observational TIGRIS (long Term rIsk, clinical manaGement and healthcare Resource utilization of stable coronary artery dISease) registry included 8406 patients aged ≥50 years with ≥1 atherothrombotic risk factor who were 1-3 years post-MI. Patient characteristics were summarised by history of AF. Quality of life was assessed at baseline using EQ-5D. Clinical outcomes over 2 years of follow-up were compared. History of AF was present in 702/8277 (8.5%) registry patients and incident AF was diagnosed in 244/7575 (3.2%) over 2 years. Those with AF were older and had more comorbidities than those without AF. After multivariable adjustment, patients with AF had lower self-reported quality-of-life scores (EQ-5D UK-weighted index, visual analogue scale, usual activities and pain/discomfort) than those without AF. CHA2DS2-VASc score ≥2 was present in 686/702 (97.7%) patients with AF, although only 348/702 (49.6%) were on oral anticoagulants at enrolment. Patients with AF had higher rates of all-cause hospitalisation (adjusted rate ratio 1.25 [1.06-1.46], p=0.008) over 2 years than those without AF, but similar rates of mortality.In stable patients post-MI, those with AF were commonly undertreated with oral anticoagulants, had poorer quality of life and had increased risk of clinical outcomes than those without AF.ClinicalTrials: NCT01866904.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Open heart

DOI

EISSN

2053-3624

ISSN

2053-3624

Publication Date

December 2021

Volume

8

Issue

2

Start / End Page

e001726

Related Subject Headings

  • Time Factors
  • Survival Rate
  • Registries
  • Quality of Life
  • Prospective Studies
  • Prevalence
  • Myocardial Infarction
  • Male
  • Humans
  • Global Health
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Carnicelli, A. P., Owen, R., Pocock, S. J., Brieger, D. B., Yasuda, S., Nicolau, J. C., … Granger, C. B. (2021). Atrial fibrillation and clinical outcomes 1 to 3 years after myocardial infarction. Open Heart, 8(2), e001726. https://doi.org/10.1136/openhrt-2021-001726
Carnicelli, Anthony P., Ruth Owen, Stuart J. Pocock, David B. Brieger, Satoshi Yasuda, Jose Carlos Nicolau, Shaun G. Goodman, et al. “Atrial fibrillation and clinical outcomes 1 to 3 years after myocardial infarction.Open Heart 8, no. 2 (December 2021): e001726. https://doi.org/10.1136/openhrt-2021-001726.
Carnicelli AP, Owen R, Pocock SJ, Brieger DB, Yasuda S, Nicolau JC, et al. Atrial fibrillation and clinical outcomes 1 to 3 years after myocardial infarction. Open heart. 2021 Dec;8(2):e001726.
Carnicelli, Anthony P., et al. “Atrial fibrillation and clinical outcomes 1 to 3 years after myocardial infarction.Open Heart, vol. 8, no. 2, Dec. 2021, p. e001726. Epmc, doi:10.1136/openhrt-2021-001726.
Carnicelli AP, Owen R, Pocock SJ, Brieger DB, Yasuda S, Nicolau JC, Goodman SG, Cohen MG, Simon T, Westermann D, Hedman K, Andersson Sundell K, Granger CB. Atrial fibrillation and clinical outcomes 1 to 3 years after myocardial infarction. Open heart. 2021 Dec;8(2):e001726.

Published In

Open heart

DOI

EISSN

2053-3624

ISSN

2053-3624

Publication Date

December 2021

Volume

8

Issue

2

Start / End Page

e001726

Related Subject Headings

  • Time Factors
  • Survival Rate
  • Registries
  • Quality of Life
  • Prospective Studies
  • Prevalence
  • Myocardial Infarction
  • Male
  • Humans
  • Global Health